Ansa Biotechnologies
Latest round
- Series B
Last raised
- Oct 2025
Total raised
- $121M
Investors
- 16
About Ansa Biotechnologies
Founded in 2018 and based in California, US, Ansa Biotechnologies, Inc. is a biotechnology firm focused on the synthesis of complex DNA sequences using proprietary enzymatic technology, providing solutions for researchers across various scientific fields.
Who invested in Ansa Biotechnologies
16 investors across 3 rounds
See all investors in Ansa Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ansa Biotechnologies
Who invested in Ansa Biotechnologies?
Ansa Biotechnologies has 16 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ansa Biotechnologies raised?
Ansa Biotechnologies has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Ansa Biotechnologies last raise money?
Ansa Biotechnologies's most recent round on record is a Series B, in Oct 2025.
What does Ansa Biotechnologies do?
Founded in 2018 and based in California, US, Ansa Biotechnologies, Inc.
Where is Ansa Biotechnologies headquartered?
Ansa Biotechnologies is headquartered in Emeryville, US.
Which VCs invest in companies like Ansa Biotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ansa Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Ansa Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.